plantar wart
Information
- Disease name
- plantar wart
- Disease ID
- DOID:13775
- Description
- "A viral infectious disease that results_in benign epithelial tumors located_in skin of the sole or toes of the foot, has_material_basis_in human papillomavirus (types 1, 2, 4 or 63), has_symptom lesions that appear on the sole of the foot." [url:http\://en.wikipedia.org/wiki/Plantar_wart]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03183765 | Completed | Phase 4 | Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts | August 1, 2017 | May 1, 2018 |
| NCT05115669 | Completed | N/A | Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts | October 12, 2021 | May 1, 2022 |
| NCT00328991 | Completed | N/A | Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts | October 2004 | December 2005 |
| NCT05588999 | Completed | Phase 1 | Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy Plus Salicylic Acid Dressing for Planter Warts | March 1, 2022 | August 31, 2022 |
| NCT01536834 | Completed | N/A | Safety & Performance Study of Verruca Treatment Device | June 2012 | February 2013 |
| NCT05592041 | Completed | Early Phase 1 | Studying of Natural Constituents' Treatment of Plantar Warts | October 20, 2022 | January 10, 2023 |
| NCT05599971 | Not yet recruiting | N/A | Intralesional Injection of Combined Digoxin and Furosemide Versus 5-Flurouracil in Plantar Warts | February 22, 2023 | February 1, 2024 |
| NCT06261684 | Recruiting | Phase 2/Phase 3 | Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial. | October 1, 2023 | October 1, 2024 |
| NCT03977753 | Recruiting | Phase 4 | Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts | February 17, 2020 | March 16, 2024 |
| NCT05488860 | Recruiting | N/A | Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases | July 30, 2022 | July 31, 2024 |
| NCT05520658 | Recruiting | N/A | Evaluation of the Efficacy of Intralesional Injection of Combined Digoxin and Furosemide Versus 5 - Fluorouracil in Treatment of Plantar Warts | July 1, 2022 | September 2022 |
| NCT06214559 | Recruiting | N/A | Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts. | February 19, 2024 | April 2024 |
| NCT02151630 | Unknown status | Phase 2/Phase 3 | Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts | May 2014 | September 2014 |
| NCT05057663 | Unknown status | N/A | Intralesional Treatment of Plantar Wart | November 1, 2021 | September 1, 2022 |
| NCT05198180 | Unknown status | Phase 3 | Treatment of Plantar Warts | February 2022 | December 2022 |
| NCT05324904 | Unknown status | N/A | Intralesional Vitamin D3 Versus Intralesional Acyclovir in Treatment of Plantar Warts | October 2022 | November 2023 |
| NCT04654091 | Unknown status | N/A | Cryotherapy VS. Nitric-zinc Complex in the Treatment of Plantar Warts. | January 1, 2021 | December 31, 2021 |
| NCT04823845 | Withdrawn | Early Phase 1 | Plantar Wart Treatment Using Adapalene Gel | May 1, 2022 | February 10, 2023 |
- Disase is a (Disease Ontology)
- DOID:934
- Cross Reference ID (Disease Ontology)
- ICD10CM:B07.0
- Cross Reference ID (Disease Ontology)
- ICD9CM:078.12
- Cross Reference ID (Disease Ontology)
- NCI:C26913
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:154363006
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0042548
- Exact Synonym (Disease Ontology)
- Verruca plantaris